Role of A(2A) adenosine receptors in regulation of opsonized E. coli-induced macrophage function
- PMID: 18404457
- PMCID: PMC2072923
- DOI: 10.1007/s11302-007-9075-x
Role of A(2A) adenosine receptors in regulation of opsonized E. coli-induced macrophage function
Abstract
Adenosine is a biologically active molecule that is formed at sites of metabolic stress associated with trauma and inflammation, and its systemic level reaches high concentrations in sepsis. We have recently shown that inactivation of A(2A) adenosine receptors decreases bacterial burden as well as IL-10, IL-6, and MIP-2 production in mice that were made septic by cecal ligation and puncture (CLP). Macrophages are important in both elimination of pathogens and cytokine production in sepsis. Therefore, in the present study, we questioned whether macrophages are responsible for the decreased bacterial load and cytokine production in A(2A) receptor-inactivated septic mice. We showed that A(2A) KO and WT peritoneal macrophages obtained from septic animals were equally effective in phagocytosing opsonized E. coli. IL-10 production induced by opsonized E. coli was decreased in macrophages obtained from septic A(2A) KO mice as compared to WT counterparts. In contrast, the release of IL-6 and MIP-2 induced by opsonized E. coli was higher in septic A(2A) KO macrophages than WT macrophages. These results suggest that peritoneal macrophages are not responsible for the decreased bacterial load and diminished MIP-2 and IL-6 production that are observed in septic A(2A) KO mice. In contrast, peritoneal macrophages may contribute to the suppressive effect of A(2A) receptor inactivation on IL-10 production during sepsis.
Keywords: Adenosine; Cytokines; Inflammation; Macrophages; Phagocytosis; Sepsis.
Figures




Similar articles
-
A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice.J Immunol. 2011 Feb 15;186(4):2444-53. doi: 10.4049/jimmunol.1001567. Epub 2011 Jan 17. J Immunol. 2011. PMID: 21242513 Free PMC article.
-
Protective role of the novel cytokine Metrnl/ interleukin-41 in host immunity defense during sepsis by promoting macrophage recruitment and modulating Treg/Th17 immune cell balance.Clin Immunol. 2023 Sep;254:109690. doi: 10.1016/j.clim.2023.109690. Epub 2023 Jul 7. Clin Immunol. 2023. PMID: 37423488
-
Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice.Shock. 2011 Apr;35(4):382-7. doi: 10.1097/SHK.0b013e3182085f12. Shock. 2011. PMID: 21192284 Free PMC article.
-
CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.J Hepatol. 2017 Oct;67(4):716-726. doi: 10.1016/j.jhep.2017.05.021. Epub 2017 May 26. J Hepatol. 2017. PMID: 28554875 Free PMC article.
-
Inhibition of the NLRP3/IL-1β axis protects against sepsis-induced cardiomyopathy.J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1653-1668. doi: 10.1002/jcsm.12763. Epub 2021 Sep 2. J Cachexia Sarcopenia Muscle. 2021. PMID: 34472725 Free PMC article.
Cited by
-
Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances.Front Immunol. 2018 Apr 27;9:852. doi: 10.3389/fimmu.2018.00852. eCollection 2018. Front Immunol. 2018. PMID: 29780382 Free PMC article.
-
Immunomodulatory and Inhibitory Effect of Immulina®, and Immunloges® in the Ig-E Mediated Activation of RBL-2H3 Cells. A New Role in Allergic Inflammatory Responses.Plants (Basel). 2018 Feb 26;7(1):13. doi: 10.3390/plants7010013. Plants (Basel). 2018. PMID: 29495393 Free PMC article.
-
Purinergic signalling and immune cells.Purinergic Signal. 2014 Dec;10(4):529-64. doi: 10.1007/s11302-014-9427-2. Epub 2014 Oct 29. Purinergic Signal. 2014. PMID: 25352330 Free PMC article. Review.
-
Regulation of macrophage function by adenosine.Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):865-9. doi: 10.1161/ATVBAHA.111.226852. Arterioscler Thromb Vasc Biol. 2012. PMID: 22423038 Free PMC article. Review.
-
Adenosine promotes alternative macrophage activation via A2A and A2B receptors.FASEB J. 2012 Jan;26(1):376-86. doi: 10.1096/fj.11-190934. Epub 2011 Sep 16. FASEB J. 2012. PMID: 21926236 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00003246-200107000-00002', 'is_inner': False, 'url': 'https://doi.org/10.1097/00003246-200107000-00002'}, {'type': 'PubMed', 'value': '11445675', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11445675/'}]}
- Angus DC, Linde-Zwirble WT, Lidicker J et al (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa022139', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa022139'}, {'type': 'PubMed', 'value': '12700374', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12700374/'}]}
- Martin GS, Mannino DM, Eaton S et al (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1189/jlb.0503214', 'is_inner': False, 'url': 'https://doi.org/10.1189/jlb.0503214'}, {'type': 'PubMed', 'value': '14557384', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14557384/'}]}
- Benjamim CF, Hogaboam CM, Kunkel SL (2004) The chronic consequences of severe sepsis. J Leukocyte Biol 75:408–412 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00003246-200201001-00008', 'is_inner': False, 'url': 'https://doi.org/10.1097/00003246-200201001-00008'}, {'type': 'PubMed', 'value': '11839946', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11839946/'}]}
- Oberholzer A, Oberholzer C, Moldawer LL (2002) Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30:58–63 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMra021333', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmra021333'}, {'type': 'PubMed', 'value': '12519925', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12519925/'}]}
- Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous